Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
KRYS | Krystal Biotech, Inc. | Director | $410 K | -$3.28 M | -88.9% | Jun 30, 2024 |
RVNC | Revance Therapeutics, Inc. | Director | $172 K | May 1, 2024 | ||
OTLK | Outlook Therapeutics, Inc. | Director | Mar 7, 2024 |
Sym | Company | Class | Transaction | % | Value $ | Price $ | Shares | Shares After | Date | Ownership |
---|